Evidence map›Paper›PMID 42094050›Full record

ArticleResearch square2026

Ligand-Mediated Proteome Remodeling Shapes Nanoparticle Protein Corona Composition for Deep Plasma Profiling.

Bahareh Ghaffari, Liuchenxin Han, Ali Tamadon, Alphan Alpaydin, Ghafar Yerima, Nick Wills, Shaun Grumelot, Danilo Ritz, Alexander Schmidt, Sylvain Peuget and 6 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bahareh GhaffariDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, USA.ORCID 0000-0003-0126-334X
Liuchenxin HanDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, Sweden.
Ali TamadonMolecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California Berkeley, Berkeley, CA, USA.
Alphan AlpaydinPrecision Health Program, Michigan State University, East Lansing, Michigan 48823, USA.ORCID 0009-0006-3231-4700
Ghafar YerimaMolecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California Berkeley, Berkeley, CA, USA.ORCID 0009-0003-5292-8505
Nick WillsDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, USA.
Shaun GrumelotPrecision Health Program, Michigan State University, East Lansing, Michigan 48823, USA.
Danilo RitzProteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.ORCID 0009-0004-8603-9754
Alexander SchmidtProteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-3149-2381
Sylvain PeugetDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, Sweden.
Mohammad GhassemiDepartment of Computer Science and Engineering, Michigan State University, East Lansing, Michigan 48824, USA.ORCID 0000-0001-7004-4859
Hojatollah ValiDepartment of Anatomy and Cell Biology, McGill University, Montreal, QC, H3A 0C7, Canada.
Mohammad R K MofradMolecular Cell Biomechanics Laboratory, Departments of Bioengineering and Mechanical Engineering, University of California Berkeley, Berkeley, CA, USA.
Amir Ata SaeiDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 77, Sweden.ORCID 0000-0002-2639-6328
Babak BorhanDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, USA.ORCID 0000-0002-3193-0732
Morteza MahmoudiPrecision Health Program, Michigan State University, East Lansing, Michigan 48823, USA.ORCID 0000-0002-2575-9684

Funding

A Nanostructured Skin Patch to Heal Chronic WoundsR01DK131417 · NIDDK · MICHIGAN STATE UNIVERSITY · PI Morteza Mahmoudi · 2022 to 2026
$2.0M
NIDDK NIH HHS R01 DK131417
6 · The paper itself

Abstract

The human plasma proteome contains extensive diagnostic information but remains difficult to interrogate because protein concentrations span more than ten orders of magnitude, with highly abundant proteins such as albumin masking low-abundance biomarkers. Nanoparticle (NP) enrichment strategies partially address this limitation, but their analytical depth is still constrained the incorporation of albumin and other highly abundant proteins within the protein corona. Here we show that the NP protein corona can be rationally reprogrammed by pre-incubating plasma with a chemically diverse panel of ligands designed to bind albumin, attenuate its interaction with NPs, and promote enrichment of lower-abundance proteins. Molecular docking and structural analyses demonstrate that these ligands induce allosteric conformational changes and surface charge redistribution on albumin, thereby reducing its association with the NP surface. Importantly, this strategy is highly tunable, as individual ligands shift protein corona composition toward different broad families of proteins, revealing overall enrichment trends rather than strict selectivity for any single class. Using this approach, we quantified over 6,600 proteins from a single human plasma sample across a curated panel of conditions, substantially exceeding the depth achieved with untreated NP enrichment. These findings establish a versatile chem-bio strategy for ligand-directed protein corona engineering, enabling high-depth plasma proteome profiling and expanding access to low-abundance proteins and candidate biomarkers across human diseases.

Identifiers

PMID42094050
PMCPMC13142641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.